Changes in the expression of meteorin-like (METRNL), irisin (FNDC5), and uncoupling proteins (UCPs) after bariatric surgery
Affiliations
Affiliations
- Department of Surgery, Faculty of Medicine, Health Sciences Centre, Kuwait University, Kuwait City, Kuwait.
- Department of Organ Transplant, Faculty of Medicine, Health Sciences Centre, Kuwait University, Kuwait City, Kuwait.
- Department of Surgery, Jaber Al-Ahmed Hospital, Kuwait City, Kuwait.
- Department of Pharmacology and Toxicology, Faculty of Medicine, Health Sciences Centre, Kuwait University, Kuwait City, Kuwait.
- Department of Pathology, Faculty of Medicine, Health Sciences Centre, Kuwait University, Kuwait City, Kuwait.
- Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Centre, Kuwait University, Kuwait City, Kuwait.
- Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Kuwait City, Kuwait.
- Special Service Facility, Dasman Diabetes Institute, Kuwait City, Kuwait.
Abstract
Objective: Bariatric surgery is currently the most effective treatment for severe obesity. This study aims to investigate the changes in expression levels of meteorin-like protein (METRNL), irisin (FNDC5), and uncoupling proteins (UCP) 1/2/3 following bariatric surgery to understand their involvement in enhancing metabolism after surgery.
Method: A total of 40 participants were enrolled in this interventional study, 20 with obesity BMI ≥ 35 kg/m2 and 20 with BMI ≤ 25 kg/m2 . Bariatric surgery (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) was performed. The levels of various molecules of interest were analyzed before and after surgery.
Results: Gene expression analysis revealed significantly higher levels of METRNL, UCP1, and UCP3 in individuals with obesity when compared with healthy individuals before surgery (p < 0.05). Gene expression levels of METRNL and UCP2 showed a significant increase after bariatric surgery (p < 0.05). METRNL plasma level was significantly higher in individuals with obesity before surgery (mean [SEM], 55,222.6 [1,421.1] pg/mL, p = 0.0319), as well as at 6 and 12 months (57,537.3 [1,303.9] pg/mL, p = 0.0005; 59,334.9 [1,214.3] pg/mL, p < 0.0001) after surgery.
Conclusion: The changes in the levels of various molecules of interest support their possible involvement in the inflammatory and thermogenic responses following bariatric surgery.
Similar articles
Jamal MH, Abu-Farha M, Al-Khaledi G, Al-Sabah S, Ali H, Cherian P, Al-Khairi I, AlOtaibi F, Al-Ali W, Bosso M, Dsouza C, Abubaker J, Al-Mulla F.Surg Obes Relat Dis. 2020 Dec;16(12):1910-1918. doi: 10.1016/j.soard.2020.07.022. Epub 2020 Jul 31.PMID: 32861644
Aleassa EM.Surg Obes Relat Dis. 2020 Dec;16(12):1918-1919. doi: 10.1016/j.soard.2020.08.027. Epub 2020 Aug 29.PMID: 33032915 No abstract available.
The influence of bariatric surgery on serum levels of irisin and nesfatin-1.
Majorczyk M, Staszkiewicz M, Szklarczyk J, Major P, Pisarska M, Wysocki M, Stefura T, Kacprzyk A, Droś J, Hołda MK, Pędziwiatr M, Budzyński A, Jaworek J.Acta Chir Belg. 2019 Dec;119(6):363-369. doi: 10.1080/00015458.2018.1534393. Epub 2018 Nov 2.PMID: 30388390
Surgery for weight loss in adults.
Colquitt JL, Pickett K, Loveman E, Frampton GK.Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.PMID: 25105982 Free PMC article. Review.
Şekerci G, Erden Y, Tekin S.Mol Biol Rep. 2022 Jul;49(7):5919-5925. doi: 10.1007/s11033-022-07374-5. Epub 2022 Mar 24.PMID: 35332411
Cited by
Li Z, Gao Z, Sun T, Zhang S, Yang S, Zheng M, Shen H.Front Immunol. 2023 Feb 24;14:1098570. doi: 10.3389/fimmu.2023.1098570. eCollection 2023.PMID: 36911663 Free PMC article. Review.
References
-
- Vetter ML, Ritter S, Wadden TA, Sarwer DB. Comparison of bariatric surgical procedures for diabetes remission: efficacy and mechanisms. Diabetes Spectr. 2012;25:200-210.
-
- Oliveira BAP, Pinhel MAS, Nicoletti CF, et al. UCP1 and UCP3 expression is associated with lipid and carbohydrate oxidation and body composition. PLoS One. 2016;11:e0150811. doi:10.1371/journal.pone.0150811
-
- Jamal MH, Aminian A. Bariatric surgery: is it a safe treatment modality? Kuwait Med J. 2015;47:193-200.
-
- Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic roux-En Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003:238;467-485.
-
- Lau RG, Radin M, Brathwaite CE, Ragolia L. Understanding the effects of roux-en-Y gastric bypass (RYGB) surgery on type 2 diabetes mellitus. In: Masuo K, ed. Type 2 Diabetes. IntechOpen; 2013. doi:10.5772/56398
-
- Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-1576.
-
- Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585.
-
- Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding, and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-323.
-
- Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308:1122-1131.
-
- Meijer RI, van Wagensveld BA, Siegert CE, et al. Bariatric surgery as a novel treatment for type 2 diabetes mellitus: a systematic review. Arch Surg. 2011;146:744-750.
-
- Jamal MH, Abu-Farha M, Al-Khaledi G, et al. Effect of sleeve gastrectomy on the expression of meteorin-like (METRNL) and irisin (FNDC5) in muscle and brown adipose tissue and its impact on uncoupling proteins in diet-induced obesity rats. Surg Obes Relat Dis. 2020;16:1910-1918.
-
- Li ZY, Zheng SL, Wang P, et al. Subfatin is a novel adipokine and unlike meteorin in adipose and brain expression. CNS Neurosci Ther. 2014;20:344-354.
-
- Jørgensen JR, Fransson A, Fjord-Larsen L, et al. Cometin is a novel neurotrophic factor that promotes neurite outgrowth and neuroblast migration in vitro and supports survival of spiral ganglion neurons in vivo. Exp Neurol. 2012;233:172-181.
-
- Zheng SL, Li ZY, Song J, Liu JM, Miao CY. Metrnl: a secreted protein with new emerging functions. Acta Pharmacol Sin. 2016;37:571-579.
-
- Rao RR, Long JZ, White JP, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014;157:1279-1291.
-
- Dadmanesh M, Aghajani H, Fadaei R, Ghorban K. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. PloS One. 2018;13:e0204180. doi:10.1371/journal.pone.0204180
-
- Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
-
- Novelle MG, Contreras C, Romero-Picó A, López M, Diéguez C. Irisin, two years later. Int J Endocrinol. 2013;2013:746281. doi:10.1155/2013/746281
-
- AlKhairi I, Cherian P, Abu-Farha M, et al. Increased expression of meteorin-like hormone in type 2 diabetes and obesity and its association with irisin. Cells. 2019;8:1283. doi:10.3390/cells8101283
-
- Bouillaud F, Alves-Guerra MC, Ricquier D. UCPs, at the interface between bioenergetics and metabolism. Biochim Biophys Acta. 2016;1863:2443-2456.
-
- Brondani LA, Assmann TS, Duarte GC, Gross JL, Canani LH, Crispim D. The role of the uncoupling protein 1 (UCP1) on the development of obesity and type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2012;56:215-225.
-
- Souza BM, Assmann TS, Kliemann LM, Gross JL, Canani LH, Crispim D. The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications. Arq Bras Endocrinol Metabol. 2011;55:239-248.
-
- Pohl EE, Rupprecht A, Macher G, Hilse KE. Important trends in UCP3 investigation. Front Physiol. 2019;10:470. doi:10.3389/fphys.2019.00470
-
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) method. Methods. 2001;25:402-408.
-
- Kohli R, Stefater MA, Inge TH. Molecular insights from bariatric surgery. Rev Endocr Metab Disord. 2011;12:211-217.
-
- Pourahmad J, Salimi A. Isolated human peripheral blood mononuclear cell (PBMC), a cost effective tool for predicting immunosuppressive effects of drugs and xenobiotics. Iran J Pharm Res. 2015;14:979-980.
-
- Visvikis-Siest S, Marteau JB, Samara A, Berrahmoune H, Marie B, Pfister M. Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems. Clin Chem Lab Med. 2007;45:1154-1168.
-
- Van Belleghem JD, Clement F, Merabishvili M, Lavigne R, Vaneechoutte M. Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci Rep. 2017;7:8004. doi:10.1038/s41598-017-08336-9
-
- Miao ZW, Hu WJ, Li ZY, Miao CY. Involvement of the secreted protein metrnl in human diseases. Acta Pharmacol Sin. 2020;41:1525-1530.
-
- Mazur-Bialy AI, Pocheć E, Zarawski M. Anti-inflammatory properties of irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. Int J Mol Sci. 2017;18:701. doi:10.3390/ijms18040701
-
- Haines B, Li PA. Overexpression of mitochondrial uncoupling protein 2 inhibits inflammatory cytokines and activates cell survival factors after cerebral ischemia. PLoS One. 2012;7:e31739. doi:10.1371/journal.pone.0031739
-
- Ikeda K, Yamada T. UCP1 dependent and independent thermogenesis in brown and beige adipocytes. Front Endocrinol (Lausanne). 2020;11:498. doi:10.3389/fendo.2020.00498
-
- Seyedrafie A, Sepideh A. Brown fat tissue: therapeutic potential for insulin resistance, new hopes for tomorrow. New Insights in Obesity: Genetics and Beyond. 2020;4:022-023. doi:10.29328/journal.niogb.1001014
-
- van Dierendonck XAMH, Sancerni T, Alves-Guerra MC, Stienstra R. The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance. J Biol Chem. 2020;295:17535-17548.
-
- Marseglia L, Manti S, D'Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16:378-400.
-
- Huizing M, Ruitenbeek W, van den Heuvel LP, et al. Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders. J Bioenerg Biomembr. 1998;30:277-284.
-
- Forte M, Bianchi F, Cotugno M, et al. An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation. Cell Death Dis. 2021;12:919. doi:10.1038/s41419-021-04188-4
-
- Horn RC, Gelatti GT, Mori NC, et al. Obesity, bariatric surgery and oxidative stress. Rev Assoc Med Bras (1992). 2017;63:229-235.
-
- Fisler JS, Warden CH. Uncoupling proteins, dietary fat and the metabolic syndrome. Nutr Metab (Lond). 2006;3:38. doi:10.1186/1743-7075-3-38
-
- O'Connor EB, Muñoz-Wolf N, Leon G, et al. UCP3 reciprocally controls CD4+ Th17 and Treg cell differentiation. PloS One. 2020;15:e0239713. doi:10.1371/journal.pone.0239713
-
- Schrauwen P, Hesselink MKC. The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity? Proc Nutr Soc. 2004;63:287-292.
-
- Samec S, Seydoux J, Dulloo AG. Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB J. 1998;12:715-724.
-
- Walle P, Takkunen M, Männistö V, et al. Alterations in fatty acid metabolism in response to obesity surgery combined with dietary counseling. Nutr Diabetes. 2017;7:e285. doi:10.1038/nutd.2017.33
-
- Hilse KE, Kalinovich AV, Rupprecht A, et al. The expression of UCP3 directly correlates to UCP1 abundance in brown adipose tissue. Biochim Biophys Acta. 2016;1857:72-78.